# Food Effect and CYP1A2 Induction Study in Healthy Subjects

> **NCT02168205** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 55 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Pomalidomide
- **OTHER:** Caffeine
- **OTHER:** Tobacco

## Key facts

- **NCT ID:** NCT02168205
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-30
- **Primary completion:** 2014-09-19
- **Final completion:** 2014-09-19
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168205, "Food Effect and CYP1A2 Induction Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02168205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*